One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Drug Screening Laboratory Services Market

薬物スクリーニングラボサービス市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Drug Screening Laboratory Services Market by Type (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair, and Others), End Users (Retail, Oil & Gas, Transportation, Staffing, Government, and Other Workplaces), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021-2028


Product Code : RDHC00115206
Survey : Research Dive
Publish On : September, 2021
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5700 / Question Form
5 User USD8700 / Question Form
Enterprise User USD10700 / Question Form
Abbott Laboratories, Quest Diagnostics, Clinical Reference Laboratory, Omega Laboratories, Inc., Laboratory Corporation of America Holdings, Cordant Health Solutions, Acm Global Laboratories, Millennium Health, Precision Diagnostics, and Psychemedics.

[Report Description]

According to Research Dive analysis, the drug screening laboratory services market is estimated to generate a revenue of $10,951.4 million by 2028, increasing from $4,586.4 million in 2020, at a healthy CAGR of 12.8%.
Impact Analysis of COVID-19 on the Drug Screening Laboratory Services Market:
The drug screening laboratory services market experienced a decreased growth rate during the Covid-19 pandemic. Due to lockdown and transportation restrictions, the demand and supply of drug testing kits, equipments, reagents and analyzers have reduced due to which the drug testing is negatively affected. Also, high unemployment and migration rate has led to less number of technicians to operate the laboratory. Apart from this, many drug testing laboratories have been converted to COVID centers which has also impacted the market growth in the pandemic period.
Drug Screening Laboratory Services Analysis:
Increased consumption of drugs such as marijuana, cocaine, and others among the people is expected to drive the market of drug screening laboratory services. Millennials are more inclined towards drugs and alcohol as they find these habits cooler and the only way to fit in themselves with their friends. Also, drugs are the tools for them to stay calm and satisfied. Therefore, the people become drug addicts. This factor is expected to accelerate the market growth. Some companies also conduct drug test for their employees in order to monitor their health regularly is also expected to flourish the market of drug screening Laboratory Services in the forecast timeframe.
However, inclination of people towards a healthy lifestyle and will to stop consuming drugs will restrain the market growth.
Advances in technology and testing methods are expected to provide many opportunities for the manufacturing industries in the market. Continuous innovation and advancements in the testing methods used for drug testing and screening is expected to provide a boost to the growth of the market in the near future. Currently, urine, blood and hair sample is collected to test if the person has consumed drugs or is a drug addict. New technology introduction for drug testing is likely to save much time and is a hassle free method. For instance, as per the article published in ‘American Addiction Centers’ in February 2021, a new technology ‘paper spray mass spectrometry’ is developed to examine the molecules present in a fingerprint. As the person’s body metabolizes drugs, it excretes molecules with drug traces which can easily be detected in the fingerprints by using paper spray mass spectrometry. This innovation is anticipated to rise the market growth in the coming years.
Based on type, the market has been divided into workplace drug testing and clinical toxicology testing.
The workplace drug testing sub-segment shall have the fastest market growth and it is anticipated to generate a revenue of $8,635.50 million by 2028.
Based on sample type, the market is divided into urine, oral fluid, hair and others. The urine sub-segment garnered $3,647.40 million in 2020 and is projected to grow exponentially by 2028.
Based on the end users, the market is divided into retail, oil & gas, transportation, staffing, government and other workplace. The government sub-segment is predicted to be growing significantly and it is expected to cross $2,807.50 million by 2028.
Based on geographical scope, the market was investigated across North America, Europe, Asia-Pacific, and LAMEA. The Asia-Pacific market is anticipated to rise at a growth rate of 13.10% by 2028 from the revenue generated in 2020.
The companies involved in the drug screening laboratory services market are Abbott Laboratories, Quest Diagnostics, Clinical Reference Laboratory, Omega Laboratories, Inc., Laboratory Corporation of America Holdings, Cordant Health Solutions, Acm Global Laboratories, Millennium Health, Precision Diagnostics, and Psychemedics.

CHAPTER 1:INTRODUCTION

1.1.Research methodology

1.1.1.Desk research
1.1.2.Real-time insights and validation
1.1.3.Forecast model
1.1.4.Assumptions & forecast parameters

1.1.4.1.Assumptions
1.1.4.2.Forecast parameters

CHAPTER 2:EXECUTIVE SUMMARY

2.1.360° summary
2.2.Type trends
2.3.Sample Type trends
2.4.End user trends

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key takeaways

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.2.2.1.Top winning strategies, by year
3.2.2.2.Top winning strategies, by development
3.2.2.3.Top winning strategies, by company

3.2.3.Top player positioning

3.3.Porter's five forces analysis
3.4.Market dynamics
3.5.Drivers
3.6.Restraints
3.7.Opportunities
3.8.Technology landscape
3.9.Regulatory landscape
3.10.Market value chain analysis
3.11.Strategic overview

CHAPTER 4:IMPACT OF COVID19 ON DRUG SCREENING LABORATORY SERVICES MARKET

4.1.Introduction

4.2.COVID-19 health assessment
4.3.Impact of COVID-19 on the global economy
4.4.Impact of COVID-19 on global drug screening laboratory services market

4.4.1.Technological impact
4.4.2.Investment scenario

4.5.Drug screening laboratory services market size and forecast, by region, 2020-2028

CHAPTER 5:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY TYPE

5.1.Overview

5.1.1.Market size and forecast, by type

5.2.Workplace drug testing

5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country

5.3.Clinical toxicological testing

5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country

CHAPTER 6:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE

6.1.Overview

6.1.1.Market size and forecast, by sample type

6.2.Urine

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country

6.3.Oral fluid

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country

6.4.Hair

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market share analysis, by country

6.5.Others

6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market share analysis, by country

CHAPTER 7:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET BY END USER

7.1.Overview

7.1.1.Market size and forecast, by type

7.2.Retail

7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country

7.3.Oil & Gas

7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country

7.4.Transportation

7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country

7.5.Staffing

7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country

7.6.Government

7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region
7.6.3.Market share analysis, by country

7.7.Other workplaces

7.7.1.Key market trends, growth factors and opportunities
7.7.2.Market size and forecast, by region
7.7.3.Market share analysis, by country

CHAPTER 8:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast, by region

8.2.North America

8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by type
8.2.3.Market size and forecast, by sample type
8.2.4.Market size and forecast, by end-user
8.2.5.Market size and forecast, by country

8.2.6.U.S.

8.2.6.1.Market size and forecast, by type
8.2.6.2.Market size and forecast, by sample type
8.2.6.3.Market size and forecast, by end-user

8.2.7.Canada

8.2.7.1.Market size and forecast, by type
8.2.7.2.Market size and forecast, by sample type
8.2.7.3.Market size and forecast, by end user

8.2.8.Mexico

8.2.8.1.Market size and forecast, by type
8.2.8.2.Market size and forecast, by sample type
8.2.8.3.Market size and forecast, by end user

8.3.Europe

8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by type
8.3.3.Market size and forecast, by sample type
8.3.4.Market size and forecast, by end-user
8.3.5.Market size and forecast, by country

8.3.6.Germany

8.3.6.1.Market size and forecast, by type
8.3.6.2.Market size and forecast, by sample type
8.3.6.3.Market size and forecast, by end user

8.3.7.UK

8.3.7.1.Market size and forecast, by type
8.3.7.2.Market size and forecast, by sample type
8.3.7.3.Market size and forecast, by end user

8.3.8.France

8.3.8.1.Market size and forecast, by type
8.3.8.2.Market size and forecast, by sample type
8.3.8.3.Market size and forecast, by end user

8.3.9.Italy

8.3.9.1.Market size and forecast, by type
8.3.9.2.Market size and forecast, by sample type
8.3.9.3.Market size and forecast, by end user

8.3.10.Spain

8.3.10.1.Market size and forecast, by type
8.3.10.2.Market size and forecast, by sample type
8.3.10.3.Market size and forecast, by end user

8.3.11.Rest of Europe

8.3.11.1.Market size and forecast, by type
8.3.11.2.Market size and forecast, by sample type
8.3.11.3.Market size and forecast, by end user

8.4.Asia-Pacific

8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by type
8.4.3.Market size and forecast, by sample type
8.4.4.Market size and forecast, by end user
8.4.5.Market size and forecast, by country

8.4.6.China

8.4.6.1.Market size and forecast, by type
8.4.6.2.Market size and forecast, by sample type
8.4.6.3.Market size and forecast, by end user

8.4.7.Japan

8.4.7.1.Market size and forecast, by type
8.4.7.2.Market size and forecast, by sample type
8.4.7.3.Market size and forecast, by end user

8.4.8.Australia

8.4.8.1.Market size and forecast, by type
8.4.8.2.Market size and forecast, by sample type
8.4.8.3.Market size and forecast, by end user

8.4.9.South Korea

8.4.9.1.Market size and forecast, by type
8.4.9.2.Market size and forecast, by sample type
8.4.9.3.Market size and forecast, by end user

8.4.10.India

8.4.10.1.Market size and forecast, by type
8.4.10.2.Market size and forecast, by sample type
8.4.10.3.Market size and forecast, by end user

8.4.11.Rest of Asia-Pacific

8.4.11.1.Market size and forecast, by type
8.4.11.2.Market size and forecast, by sample type
8.4.11.3.Market size and forecast, by end user

8.5.LAMEA

8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by type
8.5.3.Market size and forecast, by sample type
8.5.4.Market size and forecast, by end user
8.5.5.Market size and forecast, by country

8.5.6.Latin America

8.5.6.1.Market size and forecast, by type
8.5.6.2.Market size and forecast, by sample type
8.5.6.3.Market size and forecast, by end user

8.5.7.Middle East

8.5.7.1.Market size and forecast, by type
8.5.7.2.Market size and forecast, by sample type
8.5.7.3.Market size and forecast, by end user

8.5.8.Africa

8.5.8.1.Market size and forecast, by type
8.5.8.2.Market size and forecast, by sample type
8.5.8.3.Market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

9.1.Abbott Laboratories

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.Quest Diagnostics

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.Clinical Reference Laboratory, Inc

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Product portfolio
9.3.4.Key strategic moves and developments

9.4.Laboratory Corporation of America Holdings

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business Segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments

9.5.Cordant Health Solutions

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments

9.6.Psychemedics Corporation

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Product portfolio
9.6.4.Business performance
9.6.5.Key strategic moves and developments

9.7.ACM Global Laboratories

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Product portfolio
9.7.4.Key strategic moves and development

9.8.Omega Laboratories

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Product portfolio
9.8.4.Key strategic moves and developments

9.9.Millennium Health

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments

9.10.Precision Diagnostics

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Product portfolio

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+